Latest news with #Procter&GambleHygieneandHealthCare
Business Standard
23-06-2025
- Business
- Business Standard
P&G Hygiene appoints Gaurav Bhartia as CFO
Procter & Gamble Hygiene and Health Care said that its board has approved the appointment of Gaurav Bhartia as chief financial officer (CFO) with effect from 1 July 2025. Mrinalini Srinivasan has tendered her resignation as the chief financial officer of the company effective from closure of business hours of June 30, 2025, as she will be leaving P&G to pursue other interests outside the company. Gaurav Bhartia holds a B. Tech. degree from National Institute of Technology, Trichy. After a successful internship stint with P&G, he joined P&G full time in 2014 as a graduate from IIM Bangalore. Gaurav Bhartia currently leads Sales Finance for P&G India. He has a diverse experience spanning over a decade with P&G, across multiple categories and markets, leading transformational projects and delivering outstanding results for several important P&G businesses. In his past assignments, Bhartia has had significant contribution towards driving business growth and improving structural margins & profitability, while navigating macro-economic uncertainties. He is passionate about coaching and invests time building capability for finance and broader multi-functional teams. He is a mentor to many in the organization and fosters a culture of performance and collaboration for sustained excellence. Procter & Gamble Hygiene and Health Care engaged in the manufacturing and selling of branded packaged fast moving consumer goods in the femcare and healthcare businesses. Its portfolio includes Whisper India's leading Feminine Hygiene brand, and VICKS India's No. 1 Health Care brand and Old Spice. The companys standalone net profit increased 1.12% to Rs 156.10 crore on 0.9% fall in revenue from operations to Rs 989.13 crore in Q4 FY25 over Q4 FY24. The counter shed 0.25% to Rs 13,392.35 on the BSE.
Fashion Network
04-06-2025
- Business
- Fashion Network
Procter & Gamble Q4 net profit rises 1 percent to Rs 156 crore
Procter & Gamble Hygiene and Health Care Ltd reported a marginal increase of 1 percent in profit after tax at Rs 156 crore ($18.3 million) for the quarter ended March 31, 2025, as against Rs 154 crore in the year-ago quarter. The company, which follows the July-June financial year also saw a slight decline in revenue to Rs 992 crore, as against Rs 1,002 crore in the corresponding quarter of the previous fiscal year. Commenting on the results, V Kumar, managing director of Procter & Gamble Hygiene and Health Care in a statement said, 'We delivered balanced growth while continuing to introduce innovations that enhance the consumer experience in both our feminine care and health care portfolios.' 'We remain focused on executing our integrated growth strategy– a product portfolio of categories where performance drives brand choice, superiority (of product performance, packaging, brand communication, retail execution and consumer and customer value), productivity, constructive disruption, and an agile and accountable organization – towards long term value creation,' he added. Procter & Gamble has a strong portfolio of brands in the health, hygiene and wellness segments.
Business Standard
28-05-2025
- Business
- Business Standard
P&G Hygiene slips after Q4 PAT declines 42% QoQ to Rs 156 crore
Procter & Gamble Hygiene & Health Care fell 1.64% to Rs 13,980 after the company's net profit declined 41.88% to Rs 156.10 crore, while revenue from operations dropped 20.52% to Rs 991.63 crore in Q4 FY25 over Q3 FY25. On a year-on-year (YoY) basis, the companys net profit rose 1.12%, while revenue dipped 1.05% in Q4 FY25. Profit before tax (PBT) fell 9.1% YoY to Rs 212.66 crore during the quarter. Total expenses increased 2.08% YoY to Rs 798.10 crore. The cost of raw and packing materials consumed rose 6.95% YoY to Rs 175.40 crore, while employee benefits expense declined 17.84% YoY to Rs 49.37 crore in the same period. On a full-year basis, the company's net profit jumped 7.18% to Rs 636.59 crore on a 3.07% rise in revenue to Rs 3,374.42 crore in FY25 over FY24. Meanwhile, the companys board has recommended a final dividend of Rs 65 per equity share, amounting to a total payout of Rs 210.99 crore, subject to shareholder approval at the 61st Annual General Meeting. If approved, the dividend will be disbursed between 27 August and 23 September 2025. Procter & Gamble Hygiene and Health Care is engaged in the manufacturing and selling of branded packaged fast-moving consumer goods in the femcare and healthcare businesses.
Business Standard
28-05-2025
- Business
- Business Standard
Procter & Gamble Hygiene and Health Care standalone net profit rises 1.12% in the March 2025 quarter
Sales decline 0.90% to Rs 989.13 crore Net profit of Procter & Gamble Hygiene and Health Care rose 1.12% to Rs 156.10 crore in the quarter ended March 2025 as against Rs 154.37 crore during the previous quarter ended March 2024. Sales declined 0.90% to Rs 989.13 crore in the quarter ended March 2025 as against Rs 998.15 crore during the previous quarter ended March 2024. Particulars Quarter Ended Mar. 2025 Mar. 2024 % Var. Sales 989.13998.15 -1 OPM % 21.2025.78 - PBDT 223.01248.48 -10 PBT 212.66233.94 -9 NP 156.10154.37 1
